Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:49 AM
Ignite Modification Date:
2025-12-26 @ 11:49 AM
NCT ID:
NCT00324116
Eligibility Criteria:
Inclusion Criteria:
* Clinical and angiographic evidence of juxtafoveal or subfoveal choroidal neovascularization secondary to AMD with a total lesion size of less than 2 MPS disc areas
* Best-corrected visual acuity in the study eye greater than 54 letters (ETDRS)
* Women must be using 2 forms of effective contraception
* Adequate hematological, renal and liver functions
Exclusion Criteria:
* Any atrophy or fibrosis; any retinal hemorrhage measuring more than 1 disc area
* Any extrafoveal choroidal neovascularization
* Any intraocular surgery or thermal laser to the study eye within 3 months of enrollment
* Previous or concomitant therapy for AMD including PDT with verteporfin (Visudyne) or subfoveal/non-foveal thermal laser therapy, transpupillary thermotherapy, external beam radiation, submacular surgery.
* Presence of other causes of choroidal neovascularization, including pathological myopia, the ocular histoplasmosis syndrome, angioid streaks, choroidal rupture and multifocal choroiditis
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Study:
NCT00324116
Study Brief:
Protocol Section:
NCT00324116